tiprankstipranks
Advertisement
Advertisement
Precision to get $7.5M in proceeds from TG Therapeutics for azer-cel milestone
PremiumThe FlyPrecision to get $7.5M in proceeds from TG Therapeutics for azer-cel milestone
1M ago
TG Therapeutics Confronts Rising AI Regulatory and IP Risks That Could Pressure Costs, Strategy, and Growth
Premium
Company Announcements
TG Therapeutics Confronts Rising AI Regulatory and IP Risks That Could Pressure Costs, Strategy, and Growth
1M ago
Buy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
Premium
Ratings
Buy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
1M ago
TG Therapeutics announces long-term data on Briumvi published in JAMA Neurology
PremiumThe FlyTG Therapeutics announces long-term data on Briumvi published in JAMA Neurology
2M ago
TG Therapeutics price target lowered to $46 from $49 at JPMorgan
Premium
The Fly
TG Therapeutics price target lowered to $46 from $49 at JPMorgan
2M ago
Buy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
Premium
Ratings
Buy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
3M ago
Video: Wells Fargo dips as big bank earnings continue
PremiumThe FlyVideo: Wells Fargo dips as big bank earnings continue
3M ago
Closing Bell Movers: Glaukos slips 13% after pre-announcement
Premium
The Fly
Closing Bell Movers: Glaukos slips 13% after pre-announcement
3M ago
TG Therapeutics Announces Strong 2025 BRIUMVI Revenue Outlook
Premium
Company Announcements
TG Therapeutics Announces Strong 2025 BRIUMVI Revenue Outlook
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100